Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features
- Supplementary File 1:
PDF-Document (PDF, 302 KiB)
Gupta, N.; Gopal, K.; Wu, C.; Alshareef, A.; Chow, A.; Wu, F.; Wang, P.; Ye, X.; Bigras, G.; Lai, R. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers 2018, 10, 41. https://doi.org/10.3390/cancers10020041
Gupta N, Gopal K, Wu C, Alshareef A, Chow A, Wu F, Wang P, Ye X, Bigras G, Lai R. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers. 2018; 10(2):41. https://doi.org/10.3390/cancers10020041
Chicago/Turabian StyleGupta, Nidhi; Gopal, Keshav; Wu, Chengsheng; Alshareef, Abdulraheem; Chow, Alexandra; Wu, Fang; Wang, Peng; Ye, Xiaoxia; Bigras, Gilbert; Lai, Raymond. 2018. "Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features" Cancers 10, no. 2: 41. https://doi.org/10.3390/cancers10020041